Overview
If you are looking for an opportunity to stay informed on the latest developments in clinical trial disclosure and data transparency from the comfort of your own home or office, the upcoming Clinical Trial Disclosure and Data Transparency Virtual Conference is a meeting you won't want to miss. This virtual conference builds on the success of prior editions, leveraging insights from regulatory bodies and industry experts from around the world.
By attending, you will gain essential and timely information on global clinical trial disclosure, data sharing for secondary research, and the EU Clinical Trial Information System (CTIS), all from the convenience of your computer or mobile device. For those in R&D management, Clinical Development, Out Licensing and Merger & Acquisitions: understanding the requirements and rules around CCI disclosure and protection under EU CTR is key to mitigate potential risks relating to portfolio assets.
With a focus on transparency while protecting personal data and commercially confidential information, this conference is a must-attend for anyone involved in clinical trials.
Featured
Who should attend?
Professionals from Industry, Academia, Regulatory Authorities and other domain involved in:
- Clinical Trial Disclosure
- Data Transparency/Data Sharing
- Transparency Policies and Compliance
- CTIS specialists and key users
- Medical Writing, Medical Affairs, and Medical Communications
- Clinical Operations
- Compliance/Legal
- Clinical Data Protection
- Regulatory
- Publications
- Data Management
- Clinical/Medical Research
- Patient Advocacy
Get a sneak peek at DIA Global Clinical Trial Disclosure and Data Transparency Conference with these 2 free sessions from last year's conference!
EU CTR: Transparency, PPD, and CCI Requirements
Hear about the strategic view of achieving transparency and the utility of data in CTIS while ensuring EU remains attractive for clinical trials by ensuring sponsors commercially confidential information is protected.
CTIS/CTR: 1 Year into its full Application
What have been the experiences with the CTIS and CTR after 1 year of its application, from different stakeholders: from sponsors to regulators and national competent authorities?
Program Committee
-
Merete Joergensen, MBA, MSc • Clinical Disclosure and Transparency Expert, Former EFPIA, CREG Clinical Trials
Merete-J Consulting CVR: 34920818, Denmark -
Scott Feiner • Senior Manager, Clinical Records Management, Strategic Clinical Operations
AbbVie, United States -
Robert Paarlberg, MS • Principal
Paarlberg & Associates LLC, United States -
Matthias Zerm, PhD • Lead Expert, Clinical Trial Disclosure and R&D Processes
Merz Therapeutics Gmbh, Germany -
Thomas Schindler, PhD • Director Global Regulatory Affairs - Regulatory Operations
BioNTech SE, Germany -
Joyce Swart • Clinical Disclosure Lead
Alcon Research, LLC, United States -
Lora Killian, MBA • Clinical Trial Transparency and Disclosure Lead
Pfizer Inc, United States -
Ruediger Pankow, DrSc • Regulatory Affairs Expert, CTIS Project Owner
Germany
